Mayne Pharma Group Ltd is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing branded and generic pharmaceuticals. It operates through four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.

Pharmaceutical

Mayne Pharma

Shawn Patrick O’Brien

Sam Beale

Molly Jane Smith

Erinn Nathaniel

Terri Nataline

Meredith Gambill

Aaron Gray

Brant Schofield

Hem Pandya

Kimberly Parker

Keith Moore

Gerard G. Nahum

Daniel Moore

The Research and Development team at Mayne Pharma focuses on advancing the development of both branded and generic pharmaceuticals through innovative research, analytical advancements, and robust product development strategies. They collaborate across various functions to ensure compliance and safety in drug development while driving projects from concept to commercialization, ultimately enhancing the company’s portfolio and reinforcing its market position.

Research and Development

Sales and Commercial Operations

Leadership Team

Research and Development

About

Team members

Other teams at Mayne Pharma

Sales and Commercial Operations

Leadership Team